New York (1)

Stanford (1)

Cutaneous Angiosarcoma (1)

Epithelioid Sarcoma (1)

Sarcoma (1)

Recruiting (1)

phase 2 (1)

Memorial Sloan Kettering Cancer Center (1)

Amgen (1)

Merck Sharp & Dohme LLC (1)

pembrolizumab (1)

talimogene laherparepvec (t-vec) (1)

drug (1)

Other (1)

Interventional (1)

cutaneous angiosarcoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Feb 2, 2023